NMS · Biotechnology

BCRX (BCRX) Stock

$10.17 +2.52% NMS: BCRX Healthcare

Valuation

MetricValue
Price$10.17
Market Cap$2.58B
P/E Ratio-7.07
P/B Ratio-5.70
P/S Ratio2.75
EPS (TTM)$0.00
52-Week High$11.22
52-Week Low$6.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE101.55%
ROA-68.96%
ROCE-89.73%
Gross Margin38.97%
Operating Margin38.97%
Net Margin-40.90%
Debt/Equity-0.90
Current Ratio2.06

Annual Financials (USD)

Metric20212022202320242025
Revenue$157.0M$271.0M$331.0M$451.0M$875.0M
Operating Profit$-178.0M$-148.0M$-104.0M$-3.0M$341.0M
Net Profit$-184.0M$-247.0M$-227.0M$-89.0M$264.0M
EPS$-1.03$-1.33$-1.18$-0.43$1.21
Op Margin-113.1%-54.8%-31.3%-0.6%39.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$588.0M$550.0M$517.0M$490.0M$514.0M
Total Liabilities$695.0M$845.0M$972.0M$966.0M$633.0M
Cash$504.0M$305.0M$111.0M$105.0M$90.0M
Borrowings$593.0M$741.0M$825.0M$841.0M$439.0M

Latest News

BioCryst Appoints David W. Jenkins as Chief Scientific Officer GlobeNewswire · Jul 15, 2026 Wall Street Analysts Think BioCryst (BCRX) Could Surge 117.96%: Read This Before Placing a Bet Zacks · Jul 14, 2026 BioCryst (BCRX) Stock Looks Below Fair Value As Caution Lingers Simply Wall St. · Jul 9, 2026 Why Did PENG, ANET, BCRX Shares Surge To 52-Week Highs? Stocktwits · Jul 9, 2026 BioCryst Pharmaceuticals (BCRX) Ends Internal Discovery And Closes Birmingham Facility Simply Wall St. · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-142.0M$-162.0M$-95.0M$-52.0M$330.0M
Investing Cash Flow$13.0M$-130.0M$-134.0M$51.0M$-16.0M
Financing Cash Flow$16.0M$15.0M$-26.0M$-4.0M$-9.0M
Net Cash Flow$233.0M$-201.0M$-194.0M$-6.0M$-103.0M
Free Cash Flow$-145.0M$-163.0M$-97.0M$-53.0M$327.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-9.38
FCF Yield13.82%
Quick Ratio2.29
Interest Coverage-4.16
Return 1Y9.94%
Return 3Y27.31%
Return 5Y-44.90%

Ownership

Insiders Held1.20%
Institutions Held100.25%
Institutions Float Held101.47%
Institutional HolderSharesReport Date
Blackrock Inc.22,650,9882026-03-31
RA Capital Management, L.P.15,827,1862026-03-31
Deerfield Management Company, L.P15,038,0002026-03-31
State Street Corporation12,208,3602026-03-31
Vanguard Portfolio Management LLC11,244,6252026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARDX $3.80 +1.06% 11.04 $938.71M 0.00%
MAZE $26.72 +0.72% -8.11 $1.48B 0.00%
NTLA $12.76 +0.59% -3.80 $1.78B 0.00%
PHVS $35.17 +0.69% -9.75 $2.46B 0.00%
STOK $30.50 -1.26% -9.29 $1.97B 0.00%

About BCRX

BCRX stock trades at $10.17 with a market capitalization of $2.58B. The stock is valued at a price-to-earnings (P/E) ratio of -7.07, price-to-book of -5.70, price-to-sales of 2.75. Over the past 52 weeks the stock has ranged between $6.00 and $11.22, and currently trades 9.4% below its 52-week high.

On profitability, BCRX generates a return on equity (ROE) of 101.55% — well above the market average, a sign of a high-quality business, return on capital employed of -89.73%, an operating margin of 38.97%, a net profit margin of -40.90%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides